Articles tagged with 'regenerative medicine' & 'alzheimers' | Cedars-Sinai Medical Center

Presentations at International Society for Stem Cell Research Meeting Include Stem Cell Therapies for Eye Disease, Back Pain, Brain Disorders, and Research in Space

Chlamydia pneumoniae—a common bacterium that causes pneumonia and sinus infections—can linger in the eye and brain for years and may aggravate Alzheimer’s disease, according to a study from Cedars-Sinai. Published in Nature Communications, the …

Astronaut Peggy Whitson, PhD, has spent more time in space than any astronaut in America. She recently visited Cedars-Sinai as part of its Regenerative Medicine Seminar Series.Whitson, a biochemist with more than 38 years of space and science …

Cedars-Sinai has been awarded funding to develop an artificial intelligence-based platform that predicts drug toxicity before clinical trials begin, making trials safer for patients.More than 30% of clinical trials fail due to adverse drug …

New scientific methods could one day render animal studies—the standard in research laboratories for more than 100 years—obsolete. Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute at Cedars-Sinai, is …

The California Institute for Regenerative Medicine (CIRM) has awarded Cedars-Sinai researchers more than $20 million to study potential treatments for heart failure and an inherited type of heart disease.CIRM, a taxpayer-funded state …

Cedars-Sinai is partnering with Exobiosphere, a company that has developed scientific hardware to automate biomedical research in space and on Earth. Using this hardware, Cedars-Sinai investigators will send experiments to Haven-1, which is set to …

School is in session for more than 860 students, postdoctoral researchers, medical residents and fellows enrolled in Cedars-Sinai’s newly established Health Sciences University (HSU). They are the first to enroll in the new Chuck Lorre Allied Health …

“Young” immune cells created by Cedars-Sinai investigators reversed signs of aging and Alzheimer’s disease in the brains of laboratory mice, according to a study published in the journal Advanced Science. The immune cells, which were produced from …

Cedars-Sinai investigators are aiming to transform stem cells into the first heart and brain organoids to be created in space. Their experiments will travel aboard a mission to the International Space Station that is scheduled to lift off from the …

Cedars-Sinai physician-scientists joined peers from around the world at the Alzheimer’s Association International Conference in July. The scientific presentations at the conference included data from clinical trials of potential therapies for the …

In a preclinical study, Cedars-Sinai investigators found that boosting angiotensin converting enzyme (ACE) in key immune cells called microglia in the brain helped protect the brains of specially bred laboratory mice against Alzheimer’s disease. …

Using stem cells from patients with ALS (amyotrophic lateral sclerosis), Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness as well as effective treatments.In a study …

The Cedars-Sinai Board of Governors Regenerative Medicine Institute launched the Cedars-Sinai Center for Space Medicine Research on May 22—and marked the occasion with a visit from NASA astronaut and microbiologist Kate Rubins, PhD.“The Center for …

Prevention recently interviewed Zaldy Tan, MD, MPH, medical director of the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai, about the role of genetics in the development of Alzheimer’s disease—the most common form of …

Cedars-Sinai is a leading transplant center, with patient outcomes that consistently meet or exceed national averages. One continuing challenge, however, is the need to suppress transplant patients’ immune systems to prevent their bodies from …

The Cedars-Sinai Board of Governors Regenerative Medicine Institute is marking its 15th anniversary by further expanding its commitment to research, development of cell-based human models and therapies, and education with three new leadership …

A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood-brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows. The findings, which could help clinicians target …

Cedars-Sinai investigators are one step closer to manufacturing stem cells in space, which could speed up the development of new medical therapies on Earth. The first published data from the experiments conducted on a private space mission appeared …

Clinicians, researchers and the public are invited to learn about stem cell and gene therapies being developed throughout California at the 7th Annual Alpha Clinics Network Symposium, hosted by Cedars-Sinai on Oct. 25.“This meeting isn’t just for …

The Cedars-Sinai Board of Governors Regenerative Medicine Institute is creating a resource laboratory to help advance stem cell-based technologies throughout Cedars-Sinai and across California. The institute will serve as a hub for the development …

Higher-than-average levels of two Alzheimer’s-associated proteins—amyloid beta and tau—in the brain are linked with poorer cognition in middle-aged adults, according to a study led by Cedars-Sinai investigators and published in Alzheimer’s & …

Three recently published studies from Cedars-Sinai investigators have deepened knowledge of how changes in the eye are linked to indicators of Alzheimer’s disease in the brain. The eye-brain connection could help physicians diagnose patients with …

Cedars-Sinai is planning its first-ever attempt to produce stem cells in space and its fourth launch of stem cell experiments to the International Space Station. The NASA-funded launch is scheduled for Aug. 3 at 11 a.m. EDT/8 a.m. PDT.“We will be …

A machine learning tool developed by Cedars-Sinai investigators can answer questions about genes, drugs, and biochemical pathways associated with Alzheimer’s disease and other health conditions. Their findings were published today in the journal …

Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute and professor of Medicine and Biomedical Sciences at Cedars-Sinai, is developing new treatments and models for amyotrophic lateral sclerosis (ALS) …

Cedars-Sinai has launched a program to help people 40 and older who do not have Alzheimer’s disease but want to understand—and reduce—their risk for developing the illness.“After several decades of research, we understand that Alzheimer’s disease is …

Mitzi Gonzales, PhD, a board-certified neuropsychologist, has joined Cedars-Sinai as director of Translational Research in the Jona Goldrich Center for Alzheimer’s and Memory Disorders in the Department of Neurology at Cedars-Sinai. She will treat …

Cedars-Sinai investigators have discovered why some injured kidneys heal while others develop scarring that can lead to kidney failure. Their findings, detailed in a paper published in the peer-reviewed journal Science, could lead to the development …

Chemotherapy can be toxic to heart cells. To help protect the hearts of cancer patients, Cedars-Sinai investigators have created a three-dimensional “heart-on-a-chip” to evaluate drug safety. In a study published in the peer-reviewed journal Lab on …